Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis

Sleep Medicine Reviews

Volumn 38, Issue , 2018, Pages 177-186

  Sarkanen, Tomi O ^a,b   Alakuijala, Anniina P E ^b,c   Dauvilliers, Yves A ^d,e   Partinen, Markku M ^b,f  

^a Central Finland Central Hospital   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e National Reference Centre for Orphan Diseases   (France)

^f Vitalmed Research Centre   (Finland)

Author keywords

Autoimmune diseases; Cataplexy; H1N1; Influenza; Narcolepsy; Pandemrix; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ATTRIBUTABLE RISK; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VACCINATION; NARCOLEPSY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SYSTEMATIC REVIEW; COMPLICATION; INFLUENZA; INFLUENZA A VIRUS (H1N1); ISOLATION AND PURIFICATION; META ANALYSIS; PROCEDURES; RISK; VACCINATION;

HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NARCOLEPSY; RISK; VACCINATION;

EID: 85028308060     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2017.06.006     Document Type: Review

References (65)

1. Partinen, M., Epidemiology of sleep disorders. Montagna, P., Chokroverty, S., (eds.) Handb clin neurol, 2011, Elsevier, B.V., 275–314.
2. Hublin, C., Kaprio, J., Partinen, M., Koskenvuo, M., Heikkila, K., Koskimies, S., et al. The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort. Ann Neurol 35 (1994), 709–716.
3. Longstreth, W.T. Jr., Koepsell, T.D., Ton, T.G., Hendrickson, A.F., van Belle, G., The epidemiology of narcolepsy. Sleep 30 (2007), 13–26.
4. Silber, M.H., Krahn, L.E., Olson, E.J., Pankratz, V.S., The epidemiology of narcolepsy in Olmsted county, Minnesota: a population-based study. Sleep 25 (2002), 197–202.
5. Wijnans, L., Lecomte, C., de Vries, C., Weibel, D., Sammon, C., Hviid, A., et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 31 (2013), 1246–1254.
6. Dauvilliers, Y., Arnulf, I., Mignot, E., Narcolepsy with cataplexy. Lancet 369 (2007), 499–511.
7. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6 (2000), 991–997.
8. Partinen, M., Kornum, B.R., Plazzi, G., Jennum, P., Julkunen, I., Vaarala, O., Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 13 (2014), 600–613.
9. Nohynek, H., Jokinen, J., Partinen, M., Vaarala, O., Kirjavainen, T., Sundman, J., et al. AS03 adjuvanted H1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One, 7, 2012, e33536.
10. Heier, M.S., Gautvik, K.M., Wannag, E., Bronder, K.H., Midtlyng, E., Kamaleri, Y., et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 14 (2013), 867–871.
11. Miller, E., Andrews, N., Stellitano, L., Stowe, J., Winstone, A.M., Shneerson, J., et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ, 346, 2013, f794.
12. Medical Products Agency. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations – results of a case inventory study by the MPA in Sweden during 2009–2010, Narcolepsy – Case inventory study in Sweden 2009–2010, 2011, pp. 1–20. Available at: https://lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport_pandermrix_110630.pdf [Accessed 15 December 2016].
13. Dauvilliers, Y., Montplaisir, J., Cochen, V., Desautels, A., Einen, M., Lin, L., et al. Post-H1N1 narcolepsy-cataplexy. Sleep 33 (2010), 1428–1430.
14. O'Flanagan, D., Barret, A.S., Foley, M., Cotter, S., Bonner, C., Crowe, C., et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill 19 (2014), 15–25.
15. European Centre for Disease Prevention and Control. Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). Stockholm, 2012 [online]. Available at: http://ecdc.europa.eu/en/publications/Publications/Vaesco%20report%20FINAL%20with%20cover.pdf. [Accessed 4 December 2016].
16. Centers for Disease Control and Prevention. Final estimates for 2009–10 seasonal influenza and influenza A (H1N1) 2009 monovalent vaccination coverage – United States, August 2009 through May, 2010. Secondary final estimates for 2009–10 seasonal Influenza and influenza A (H1N1) 2009 monovalent vaccination coverage – United States, August 2009 through May, 2010, 2011 [online]. Available at: http://www.cdc.gov/flu/fluvaxview/coverage_0910estimates.htm-ref4. [Accessed 4 December 2016].
17. Han, F., Lin, L., Warby, S.C., Faraco, J., Li, J., Dong, S.X., et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70 (2011), 410–417.
18. Han, F., Lin, L., Li, J., Dong, X.S., Mignot, E., Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol, 73, 2013, 560.
19. Wu, H., Zhuang, J., Stone, W.S., Zhang, L., Zhao, Z., Wng, Z., et al. Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in Eastern China. Sleep Med 15 (2014), 607–613.
20. Tesoriero, C., Codita, A., Zhang, M.D., Cherninsky, A., Karlsson, H., Grassi-Zucconi, G., et al. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A 113 (2016), E368–E377.
21. Luca, G., Haba-Rubio, J., Dauvilliers, Y., Lammers, G.J., Overeem, S., Donjacour, C.E., et al. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 22 (2013), 482–495.
22. Sturkenboom, M.C.J.M., The narcolepsy-pandemic influenza story: can the truth ever be unraveled?. Vaccine 33:2 (2015), B6–B13.
23. Vaarala, O., Vuorela, A., Partinen, M., Baumann, M., Freitag, T.L., Meri, S., et al. Antigenic differences between AS03 adjuvanted influenza A(H1N1) pandemic vaccines: implications for Pandemrix-associated narcolepsy risk. PLoS One, 9, 2014, e114361.
24. Poli, F., Overeem, S., Lammers, G.J., Plazzi, G., Lecendreux, M., Bassetti, C.L., et al. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine 31 (2013), 994–1007.
25. Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010-final report of National Narcolepsy Study Steering Committee, (2014) Available at: http://health.gov.ie/wp-content/uploads/2014/03/Final_Report_of_National_Narcolepsy_Study_Steering_Committee.pdf. [Accesed 4th December 2016].
26. Medical Products Agency, Sweden. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - A first and preliminary report, by the Medical Products Agency, 2011 [online]. Available at: https://lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport_pandermrix_110630.pdf. [Accessed 4 December 2016].
27. Medical Products Agency, Sweden. Registerstudie med fokus på neurologiska och immunrelaterade sjukdomar efter vaccination med Pandemrix, 2013 [online]. Available at: https://lakemedelsverket.se/upload/nyheter/2013/PDX%20Rapport%20SV%20-%20registerstudie%207%20landsting%20regioner%202013-03-26.pdf. [Accesed 4 September 2016].
28. European Centre for Disease Prevention and Control. The 2009 A(H1N1) pandemic in Europe. Stockholm: European Centre for Disease Prevention and Control, 2010 [online]. Available at: http://ecdc.europa.eu/en/publications/Publications/101108_SPR_pandemic_experience.pdf. [Accessed 4th December 2016].
29. Jokinen J, Nohynek H, Honkanen J, Vaarala O, Partinen M, Hublin C, et al. Pandemiarokotteen ja narkolepsian yhteys aikuisilla - Varmennettuihin rekisteritietoihin perustuva tutkimus: THL, 2013 [online]. Available at: https://www.julkari.fi/bitstream/handle/10024/104482/URN_ISBN_978-952-245-921-3.pdf?sequence=1. [Accessed 4 December 2016].
30. Jokinen J, Nohynek H, Vaarala O, Kilpi T. Pandemiarokotteen ja narkolepsian yhteys - vuoden 2012 loppuun mennessä kertyneisiin rekisteritietoihin perustuva seurantaraportti: THL, 2014 [online]. Available at: https://www.julkari.fi/bitstream/handle/10024/116234/URN_ISBN_978-952-302-255-3.pdf?sequence=1. [Accessed 4 December 2016].
31. Netherlands Pharmacovigilance Centre Lareb. Update of Overview of Dutch cases of narcolepsy associated with Pandemrix, 2015 [online]. Available at: http://www.lareb.nl/getmedia/0834beb5-dd13-4d0a-9a5e-c545445d7a6a/Narcolepsy_Update_13nov2014.pdf. [Accessed 4 December 2016].
32. Netherlands Pharmacovigilance Centre Lareb. Update of Overview of Dutch cases of narcolepsy associated with Focetria [online]. Available at: http://www.lareb.nl/getdoc/680cdba8-809b-497a-a11e-05d9b8e2ead5/KWB_2014_1_pande. [Accessed 4 December 2016].
33. Dauvilliers, Y., Arnulf, I., Lecendreux, M., Monaca Charley, C., Franco, P., Drouot, X., et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in france. Brain 136 (2013), 2486–2496.
34. Persson, I., Granath, F., Askling, J., Ludvigsson, J.F., Olsson, T., Feltelius, N., Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med 275 (2013), 172–190.
35. Stowe, J., Miller, E., Andrews, N., Kosky, C., Leschziner, G., Shneerson, J.M., et al. Risk of narcolepsy after AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in adults: a case-coverage study in England. Sleep 39 (2016), 1051–1057.
36. Heier, M.S., Gautvik, K.M., Waanag, E., Bronder, K.H., Midtlyng, E., Kamaleri, Y., et al. Narcolepsy in Norway after 2009 +/- H1N1-vaccination - the 4 year status. J Sleep Res, 23, 2014.
37. Kallweit, U., Mathis, J., Jenni, O.G., Heinzer, R., Haba-Rubio, J., Baumann, C.R., et al. Post-H1N1 flu vaccination narcolepsy in Switzerland: a retrospective survey in the 30 sleep-certified Swiss centers. Eur Neurol 75 (2016), 105–108.
38. Choe, Y.J., Bae, G.R., Lee, D.H., No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 30 (2012), 7439–7442.
39. Cohet, C., Montplaisir, J., Petit, D., Quinn, M.-J., Ouakki, M., Deceuninck, G., et al. Applying the test-negative design to vaccine safety studies: risk of narcolepsy associated with A/H1N1 (2009) pandemic influenza vaccination in Quebec. Pharmacoepidemiol Drug Saf 24 (2015), 406–407.
40. Duffy, J., Weintraub, E., Vellozzi, C., DeStefano, F., Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 83 (2014), 1823–1830.
41. Haber, P., Moro, P.L., Cano, M., Lewis, P., Stewart, B., Shimabukuro, T.T., Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, vaccine adverse event reporting system (VAERS), July 2013-June 2014. Vaccine 33 (2015), 1987–1992.
42. Halsey, N.A., Talaat, K.R., Greenbaum, A., Mensah, E., Dudley, M.Z., Proveaux, T., et al. The safety of influenza vaccines in children: an Institute for Vaccine Safety white paper. Vaccine 33:5 (2015), F1–F67.
43. Harris, T., Wong, K., Stanford, L., Fediurek, J., Crowcroft, N., Deeks, S., Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data. Euro Surveill, 19, 2014.
44. Kim, W.J., Lee, S.D., Lee, E., Namkoong, K., Choe, K.W., Song, J.Y., et al. Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers. Vaccine 33 (2015), 4868–4872.
45. McCarthy, N.L., Gee, J., Lin, N.D., Thyagarajan, V., Pan, Y., Su, S., et al. Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine 31 (2013), 5975–5982.
46. Montplaisir, J., Petit, D., Quinn, M.-J., Ouakki, M., Deceuninck, G., Desautels, A., et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One, 9, 2014, e108489.
47. Oberle, D., Drechsel-Bauerle, U., Schmidtmann, I., Mayer, G., Keller-Stanislawski, B., Incidence of narcolepsy in Germany. Sleep 38 (2015), 1619–1628.
48. Tsai, T.F., Crucitti, A., Nacci, P., Nicolay, U., Cioppa, G.D., Ferguson, J., et al. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Inf Dis 43 (2011), 702–706.
49. Partinen, M., Saarenpaa-Heikkila, O., Ilveskoski, I., Hublin, C., Linna, M., Olsen, P., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One, 7, 2012, e33723.
50. Winstone, A.M., Stellitano, L., Verity, C., Andrews, N., Miller, E., Stowe, J., et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 56 (2014), 1117–1123.
51. Szakacs, A., Darin, N., Hallbook, T., Increased childhood incidence of narcolepsy in Western Sweden after H1N1 influenza vaccination. Neurology 80 (2013), 1315–1321.
52. Verstraeten, T., Cohet, C., Santos, G.D., Ferreira, G.L., Bollaerts, K., Bauchau, V., et al. Pandemrix and narcolepsy: a critical appraisal of the observational studies. Hum Vaccin Immunother 12 (2016), 187–193.
53. Bollaerts, K., Shinde, V., Dos Santos, G., Ferreira, G., Bauchau, V., Cohet, C., et al. Application of probabilistic multiple-bias analyses to a cohort- and a case-control study on the association between Pandemrix™ and narcolepsy. PLoS One, 11, 2016, e0149289.
54. Wijnans, L., Dodd, C., de Ridder, M., Romio, S., Weibel, D., Overeem, S., et al. Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias. Expert Rev Vaccines 15 (2016), 573–584.
55. Lopez, R., Barateau, L., Evangelista, E., Chenini, S., Robert, P., Jaussent, I., et al. Temporal changes in the cerebrospinal fluid level of hypocretin-1 and histamine in narcolepsy. Sleep, 40, 2017.
56. Sterne, J.A.C., Sutton, A.J., Ioannidis, J.P.A., Terrin, N., Jones, D.R., Lau, J., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ, 343, 2011, d4002.
57. Sarkanen, T., Alakuijala, A., Partinen, M., Clinical course of H1N1-vaccine-related narcolepsy. Sleep Med 19 (2016), 17–22.
58. Dodd, C., Ridder, M., Weibel, D., DeStefano, F., Shimabukuro, T., Carleton, B., et al. Narcolepsy incidence rates in the SOMNIA (Systematic observational method for narcolepsy and influenza immunization) study. Pharmacoepidemiol Drug Saf, 25, 2016.
59. Van Effelterre, T., Dos Santos, G., Shinde, V., Twin peaks: a/H1N1 pandemic influenza virus infection and vaccination in Norway, 2009?2010. PLoS One, 11, 2016, e0151575.
60. Melen, K., Partinen, M., Tynell, J., Sillanpaa, M., Himanen, S.L., Saarenpaa-Heikkila, O., et al. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after pandemrix vaccination campaign in Finland. PLoS One, 8, 2013, e68402.
61. Ahmed, S.S., Volkmuth, W., Duca, J., Corti, L., Pallaoro, M., Pezzicoli, A., et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. 2015.
62. Vassalli, A., Li, S., Tafti, M., Comment on “antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2”. Sci Transl Med, 7, 2015, 314le2.
63. N.S.-O.I.A.H.N.V.I. Team, Emergence of a novel swine-origin influenza A (H1N1) virus in humans, NEJM, 360 (2009). pp. 2605–2615.
64. Shrestha, S.S., Swerdlow, D.L., Borse, R.H., Prabhu, V.S., Finelli, L., Atkins, C.Y., et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 52:1 (2011), S75–S82.
65. Dawood, F.S., Iuliano, A.D., Reed, C., Meltzer, M.I., Shay, D.K., Cheng, P.-Y., et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Inf Dis 12 (2012), 687–695.